Prime Medicine, Inc. (NASDAQ: PRME) Stock Information | RedChip

Prime Medicine, Inc. (NASDAQ: PRME)


$3.1900
+0.2200 ( +4.93% ) 487.6K

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Market Data


Open


$3.1900

Previous close


$2.9700

Volume


487.6K

Market cap


$410.53M

Day range


$2.9400 - $3.2350

52 week range


$2.8500 - $9.8600

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 62 May 10, 2024
8-k 8K-related 15 May 10, 2024
ars Annual reports 1 Apr 29, 2024
def Proxies and info statements 4 Apr 29, 2024
pre Proxies and info statements 4 Apr 19, 2024
4 Insider transactions 1 Mar 04, 2024
8-k 8K-related 16 Mar 01, 2024
10-k Annual reports 115 Mar 01, 2024
3 Insider transactions 1 Feb 29, 2024
4 Insider transactions 1 Feb 27, 2024

Latest News